Kablan Ahmed, Saunders Rudel A, Szkudlarek-Mikho Maria, Chin Andrew J B, Bosio Raul M, Fujii Kazuyuki, Shapiro Joseph, Chin Khew-Voon
Department of Medicine, University of Toledo, College of Medicine, Toledo, OH, United States.
J Diabetes Metab. 2010 Sep 29;1(101). doi: 10.4172/2155-6156.1000101.
The global increase in the incidence of obesity has emerged as one of the most serious public health risks in recent years. Despite the enormity of the obesity pandemic, there are currently only two FDA-approved therapies for its treatment and these drugs exhibit modest efficacy and have limiting side effects. Prieurianin is a plant limonoid product that deters feeding in insect larvae. We investigated in this study the effects of prieurianin on weight loss and adipogenesis. Our results showed that prieurianin causes weight loss by reducing energy intake in obese mice on high-calorie diet. We also found that prieurianin is anti-adipogenic in cultured preadipocytes and adipocytes by inhibiting proliferation and differentiation of preadipocytes into adipocytes, and induces either dedifferentiation or delipidation of mature adipocytes. Whether prieurianin can potentially be used for obesity treatment in human warrants further investigation.
近年来,全球肥胖发病率的上升已成为最严重的公共卫生风险之一。尽管肥胖流行规模巨大,但目前美国食品药品监督管理局(FDA)仅批准了两种用于治疗肥胖的疗法,而且这些药物疗效一般,还存在副作用。普列乌里宁是一种植物柠檬苦素类产品,可阻止昆虫幼虫进食。在本研究中,我们调查了普列乌里宁对体重减轻和脂肪生成的影响。我们的结果表明,普列乌里宁通过减少高热量饮食喂养的肥胖小鼠的能量摄入来减轻体重。我们还发现,普列乌里宁在培养的前脂肪细胞和脂肪细胞中具有抗脂肪生成作用,它通过抑制前脂肪细胞增殖并分化为脂肪细胞来实现,还能诱导成熟脂肪细胞去分化或脱脂。普列乌里宁是否有可能用于人类肥胖治疗还有待进一步研究。